Achieve Life Sciences, Inc.
Nasdaq · Healthcare · In Vitro & In Vivo Diagnostic Substances · Seattle, WA
ACHV chart
What traders are saying about $ACHV
Latest postsAchieve Life Sciences, Inc. news
- Achieve Life Sciences Reports Q3 2026 Results, $201.5M in Cash
TradingView ·
- Cash and securities reach $201.5M as the nine-month loss widens at Achieve Life Sciences (ACHV).
Stock Titan ·
- Achieve Life Sciences, Inc. will Change its Ticker to QUIT from ACHV
marketscreener.com ·
- Achieve Life Sciences (NASDAQ:ACHV) Announces Earnings Results
MarketBeat ·
- Achieve Life Sciences, Inc. Revenue Breakdown – NASDAQ:QUIT
TradingView ·
- Achieve Life Sciences, Inc. Financial Statements – NASDAQ:QUIT
TradingView ·
- Achieve Life Sciences Q3 Results: EPS loss narrows 60.71% YoY to $(0.11)
scanx.trade ·
- AchieveRx Reports Third Quarter 2026 Financial Results and Provides Business Updates
Yahoo Finance ·
- A yearlong trial found 31.2% quit among adults still smoking or vaping after an earlier attempt
Stock Titan ·
- Achieve Life Sciences, Inc. (NASDAQ:ACHV) Stock Has Average Target Price of $15.50 According to Brokerages
MarketBeat ·
- Achieve Life Sciences Q3 2026 Earnings Results and Report
MarketBeat ·
- Achieve Life Sciences Rebrands as AchieveRx, The Quit Company
marketscreener.com ·
Achieve Life Sciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$54.6M | -$39.8M | -$29.8M | -$42.4M |
| Diluted EPS | $-1.25 | $-1.24 | $-1.50 | $-4.00 |
| Total assets (year end) | $41.8M | $38.6M | $19.4M | $30.0M |
| Cash and equivalents (year end) | $20.9M | $12.8M | $15.5M | $24.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Achieve Life Sciences, Inc.
- Ticker
- ACHV (Nasdaq)
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Seattle, WA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 949858
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Frequently asked questions
What exchange is Achieve Life Sciences, Inc. listed on?
Achieve Life Sciences, Inc. trades on the Nasdaq under the ticker symbol ACHV.
What industry is Achieve Life Sciences, Inc. in?
Achieve Life Sciences, Inc. is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.
Where is Achieve Life Sciences, Inc. headquartered?
Achieve Life Sciences, Inc.'s business address on file with the SEC is in Seattle, WA.
When does Achieve Life Sciences, Inc.'s fiscal year end?
Achieve Life Sciences, Inc.'s fiscal year ends on December 31.
How much revenue did Achieve Life Sciences, Inc. report?
Achieve Life Sciences, Inc. reported $0 in revenue for calendar year 2019, according to its SEC filings.